Pharmacology, Safety, and efficacy of cefamandole in childhood infections.
We used cefamandole in the initial treatment of 34 children (10 months to 15 years of age) with suspected bone, joint, or soft tissue infections. The minimal inhibitory concentration of organisms encountered ranged between 0.015 and 2 microgram/ml. At 1 h after intravenous infusion of 25 mg/kg, the...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1981
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181625/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7283413/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.20.1.21 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|